Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
Lisa E. Hensley(National Center for Emerging and Zoonotic Infectious Diseases), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Clement Asiedu(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Sabue Mulangu(National Institutes of Health), Peter B. Jahrling(National Institutes of Health), Victoria Wahl‐Jensen(United States Army Medical Research Institute of Infectious Diseases), Joshua C. Johnson(National Institutes of Health), Giulia Fabozzi(National Institutes of Health), Pierre E. Rollin(Université Claude Bernard Lyon 1), Mario Roederer(National Institutes of Health), Daphne A. Stanley(National Institutes of Health), Stuart T. Nichol(Centers for Disease Control and Prevention), Michael Bailey(General Department of Preventive Medicine), Thomas G. Ksiazek(The University of Texas Medical Branch at Galveston), Anna N. Honko
Cited by 145
Related Papers
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k